Carvedilol vs. Doxazosin mesylate: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Carvedilol and Doxazosin mesylate. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 212,830 people who take Carvedilol and Doxazosin mesylate, and is updated regularly.
What is Carvedilol?
Carvedilol has active ingredients of carvedilol. It is often used in high blood pressure. eHealthMe is studying from 112,649 Carvedilol users. Check the latest studies of Carvedilol.
What is Doxazosin mesylate?
Doxazosin mesylate has active ingredients of doxazosin mesylate. It is often used in high blood pressure. eHealthMe is studying from 11,975 Doxazosin mesylate users. Check the latest studies of Doxazosin mesylate.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
212,830 people who take Carvedilol and Doxazosin mesylate are studied.
Drugs being compared in this study:
- Doxazosin Mesylate (doxazosin mesylate)
- Carvedilol (carvedilol)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Carvedilol:
- not at all: 2.04 %
- somewhat: 15.84 %
- moderate: 34.87 %
- high: 35.96 %
- very high: 11.29 %
Doxazosin Mesylate:
- not at all: 2.46 %
- somewhat: 21.69 %
- moderate: 41.54 %
- high: 27.69 %
- very high: 6.62 %
Want to compare Carvedilol with Doxazosin mesylate?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies
- Barold, S. S., & Upton, S. , "Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol", Case reports in cardiology, 2018 Jan .
- Kim MS, Baek IH, "Effect of dronedarone on the pharmacokinetics of carvedilol following oral administration to rats", European Journal of Pharmaceutical Sciences, 2018 Jan .
- Barold, S. S., & Upton, S. , "Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol", Case reports in cardiology, 2018 Jan .
- Kim MS, Baek IH, "Effect of dronedarone on the pharmacokinetics of carvedilol following oral administration to rats", European Journal of Pharmaceutical Sciences, 2018 Jan .
Related studies
Alternative drugs to, pros and cons of:
- Carvedilol (110,237 reports)
- Doxazosin mesylate (11,240 reports)
Browse all side effects of Carvedilol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Doxazosin mesylate:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on carvedilol and doxazosin mesylate (the active ingredients of Carvedilol and Doxazosin mesylate, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Bactrim cause Myoclonus? - a second ago
- Blincyto and Cytokine Release Syndrome for Men aged 30-39 - 5 seconds ago
- Bactrim and Lens Opacity for Men aged 60+ - 5 seconds ago
- Bactrim and Cataract for Men aged 60+ - 6 seconds ago
- Could Vitamin B12 cause Shock Haemorrhagic? - 6 seconds ago
- Could Sertraline cause Sensory Disturbance? - 8 seconds ago
- Zide and Nexium drug interactions for men aged 50-59 - 8 seconds ago
- Could Riociguat cause Cardiac Failure? - 9 seconds ago
- Drug interactions of Pomalyst and Vagifem - 9 seconds ago
- Could Taxotere cause Gastric Ulcer? - 10 seconds ago